文献速递膀胱癌与上尿路尿路上皮癌肾癌与肾肿瘤前列腺癌

吸烟与泌尿生殖系统恶性肿瘤死亡的关联:美国国家纵向死亡率研究分析

Association of Smoking and Death from Genitourinary Malignancies: Analysis of the National Longitudinal Mortality Study.
PubMed 文献 · J Urol · 2019-07-10

基于美国国家纵向死亡率研究1993至2005年493,282名提供详细烟草信息的参与者,分析吸烟参数与膀胱癌、肾癌和前列腺癌特异性死亡的关系。中位随访5年,曾吸烟者死亡比例为5.6% vs 从不吸烟者3.1%(p<0.0001)。多变量分析显示曾吸烟与膀胱癌和肾癌死亡率相关,青少年开始吸烟和家中吸烟与膀胱癌和肾癌特异性死亡相关,仅每日吸烟与前列腺癌死亡风险增加相关。

要点

  • 曾吸烟与膀胱癌死亡(HR 1.92,95%CI 1.25-2.97)和肾癌死亡(HR 1.54,95%CI 1.01-2.34)相关。
  • 青少年开始吸烟和家中吸烟与膀胱癌及肾癌特异性死亡风险升高相关。
  • 仅每日吸烟与前列腺癌死亡风险增加相关(HR 1.81,95%CI 1.30-2.53)。

核心结论

  • 在这项全国代表性研究中,证实了吸烟强度与泌尿生殖系统恶性肿瘤死亡率之间的关联。
  • 较早开始吸烟和在家中吸烟与膀胱癌和肾癌死亡风险显著升高相关。

研究设计与样本

  • 研究纳入美国国家纵向死亡率研究中1993至2005年提供详细烟草信息的493,282名参与者。
  • 主要结局为膀胱癌、肾癌或前列腺癌死亡,死因依据死亡证明确定。
  • 采用多变量Cox回归模型评估不同吸烟参数与膀胱癌、肾癌和前列腺癌特异性死亡的关联。

主要发现

  • 5年随访期间,曾吸烟者死亡比例为5.6%,从不吸烟者为3.1%(p<0.0001)。
  • 死于膀胱癌、肾癌和前列腺癌的参与者中,曾吸烟者分别占62%、58%和62%。
  • 多变量分析中,曾吸烟与膀胱癌死亡(HR 1.92,95%CI 1.25-2.97)和肾癌死亡(HR 1.54,95%CI 1.01-2.34)相关。
  • 青少年开始吸烟与膀胱癌死亡(HR 2.14,95%CI 1.28-3.56)和肾癌死亡(HR 1.65,95%CI 1.03-2.66)相关。
  • 家中吸烟与膀胱癌死亡(HR 2.99,95%CI 1.34-6.65)和肾癌死亡(HR 2.84,95%CI 1.54-5.23)相关;仅每日吸烟与前列腺癌死亡风险增加相关(HR 1.81,95%CI 1.30-2.53)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We explored the association between tobacco use and genitourinary cancer specific survival in a contemporary, nationally representative sample of the United States civilian population. MATERIALS AND METHODS: A total of 493,282 participants in the National Longitudinal Mortality Study who provided detailed tobacco information from 1993 to 2005 were included in study. Our primary outcome was death from bladder, kidney or prostate cancer. Cause of death was determined from death certificates. Analyzed smoking parameters included smoking status at the time of the survey, age at the start of smoking and home smoking rules. Multivariable Cox regression models were used to assess associations of different smoking parameters with bladder, kidney and prostate cancer specific mortality. RESULTS: During a 5-year followup 5.6% of participants who had ever smoked died compared to 3.1% of those who had never smoked (p <0.0001). Of those who died of bladder, kidney and prostate cancer 62%, 58% and 62%, respectively, were ever smokers. On multivariable analysis ever smoking was associated with bladder and kidney cancer mortality (HR 1.92, 95% CI 1.25-2.97, and HR 1.54, 95% CI 1.01-2.34, respectively). Additionally, starting to smoke during teenage years and smoking at home were associated with bladder cancer specific mortality (HR 2.14, 95% CI 1.28-3.56 and HR 2.99, 95% CI 1.34-6.65) and kidney cancer specific mortality (HR 1.65, 95% CI 1.03-2.66 and HR 2.84, 95% CI 1.54-5.23, respectively). However, only everyday smoking was associated with an increased risk of prostate cancer mortality (HR 1.81, 95% CI 1.30-2.53). CONCLUSIONS: In a nationally representative study we confirmed the association between smoking intensity and mortality from genitourinary malignancies. Starting to smoke at a younger age and smoking at home conferred a significantly higher risk of death from bladder and kidney cancers.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Al Hussein Al Awamlh B, Shoag JE, Ravikumar V, et al. Association of Smoking and Death from Genitourinary Malignancies: Analysis of the National Longitudinal Mortality Study. J Urol. 2019. PMID: 31290707. doi:10.1097/JU.0000000000000433

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。